THE EFFECTS OF L.CASEI STRAIN SHIROTA SUPPLEMENTATION ON FAECAL PROFILES AND BODY WEIGHT GAIN OF OVERWEIGHT AND OBESE MALAY CHILDREN
DOI:
https://doi.org/10.37268/mjphm/vol.22/no.3/art.1652Keywords:
Short-chain fatty acids, Probiotic, Bodyweight, Childhood obesity, HPLCAbstract
Probiotic Lactobacillus casei strain Shirota (LcS) has been proven beneficial for the treatment of gut-related conditions. However, it is unclear how it influences faecal SCFAs concentrations and how it disrupted in overweight and obese children. This study aimed to investigate the effect of LcS on faecal profiles and body weight gain in overweight (OW) and obese (OB) children. A total of 42 children, comprising 22 OW/OB children (mean age = 8.73 ± 1.03 years old; BMI = 24.73 ± 3.91 kg/m2; 54.5% boys) and 20 normal weight (NW) children (as a control), were randomly assigned to either receive daily 80 ml of probiotic drink at a dosage of 3.0 x 1010 colony-forming units (CFU) for 4 weeks or a control. Faecal samples were taken, and SCFAs were analysed by HPLC. Results: Twenty-two OW/OB participants completed the study. At the end of the fourth week of LcS supplementations, the propionate and the total SCFAs concentrations increased significantly over time with evident intervention effect (p<0.05). In the treatment group, the faecal propionate concentration (Mean= 153.57 µmol/g , SD= 142.17) increased by 161 % and total SCFAs concentration (Mean= 201.44 µmol/g , SD= 162.90) increased by 79 % from the baseline. The mean percentage of body weight changed significantly within the treatment and control groups: 6.4% in the control group and 7.4% in the treatment group (p 0.05). Nevertheless, no such significant differences were found between the treatment and control groups (p>0.05). LcS supplementations for the 4 weeks in OW/OB children were able to increase levels of propionate as compared to baseline values.
References
Hirschler V, Lapertosa S, Raquel Scaiola E, et al.; On behalf of the Dioses Study Group. Adiposity, lifestyle behaviors, and cardiometabolic markers in Argentinean school children. Clin Chim Acta. 2020;507:280–285.
Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity among adults and youth: United States, 2015–2016. NCHS Data Brief. 2017; 288: 1-8.
Pan L, Freedman DS, Sharma AJ, Castellanos-Brown K, Park S, Smith RB, Blanck HM. Trends in Obesity Among Participants Aged 2-4 Years in the Special Supplemental Nutrition Program for Women, Infants, and Children - United States, 2000-2014. MMWR Morb Mortal Wkly Rep, 2016; 65: 1256-1260.
Ells LJ, Hancock C, Copley VR, Mead E, Dinsdale H, Kinra S, Viner RM, Rutter H. Prevalence of severe childhood obesity in England: 2006-2013. Arch Dis Child, 2015; 100: 631-636.
Hudda MT, Nightingale CM, Donin AS, Owen CG, Rudnicka AR, Wells JCK, Rutter H, Cook DG, Whincup PH. Patterns of childhood body mass index (BMI), overweight and obesity in South Asian and black participants in the English National child measurement programme: effect of applying BMI adjustments standardising for ethnic differences in BMI-body fatness associations. Int J Obes (Lond), 2018; 42: 662-670
Maeda M, Maeda T, Ihara K. Secular Trends in Obesity and Serum Lipid Values among Children in Oita City, Japan, during a 27-Year Period. JAT. 2022;63056.
Ford ND, Patel SA, Narayan KMV. Obesity in Low- and Middle-Income Countries: Burden, Drivers, and Emerging Challenges. Annual Review of Public Health. 2017;38(1):145–64.
Rangelova L, Petrova S, Konstantinova M, Duleva V, Dimitrov P. Overweight and obesity prevalence in Bulgarian schoolchildren: a comparison between two international standards. Int J Biomed Adv Res. 2014;5:454–8.
Khadilkar VV, Khadilkar AV, Cole TJ, Chiplonkar SA, Pandit D. Overweight and obesity prevalence and body mass index trends in Indian children. Int J Pediatr Obes. 2011;6:e216–24.
Kelishadi R, Ardalan G, Gheiratmand R, Majdzadeh R, Hosseini M, Gouya MM, et al. Thinness, overweight and obesity in a national sample of Iranian children and adolescents: CASPIAN study. Child Care Health Dev. 2008;34:44–54.
Kobyliak N, Conte C, Cammarota G, Haley AP, Styriak I, Gaspar L, Fusek J, Rodrigo L, Kruzliak P. Probiotics in prevention and treatment of obesity: a critical view. Nutr Metab (Lond). 2016 Feb 20;13:14. doi: 10.1186/s12986-016-0067-0. PMID: 26900391; PMCID: PMC4761174.
Yang WY, Williams LT, Collins C, Siew Swee CW. The relationship between dietary patterns and overweight and obesity in children of Asian developing countries: A systematic review. JBI Database Syst. Rev.Implement. Rep., 2012; 10 (58):4568–4599. https://doi.org/10.11124/jbisrir-2012-407
Poh B, Ng B, Siti Haslinda M, Nik Shanita S, Wong J, Budin S, . . . Norimah A. Nutritional status and dietary intakes of children aged 6 months to 12 years: Findings of the Nutrition Survey of Malaysian Children (SEANUTS Malaysia). British Journal of Nutrition, 2013; 110(S3), S21-S35 https://doi.org/10.1017/S0007114513002092
Institute for Public Health. National health and morbidity survey 2015 (NHMS 2015). Vol. II: Non-communicable diseases, risk factors & other health problems. Ministry of Health. 2015. https://doi.org/10.1017/CBO9781107415324.004
Berding K, Holscher HD, Arthur AE, Donovan SM. Fecal microbiome composition and stability in 4- to 8-year old children is associated with dietary patterns and nutrient intake. J Nutr Biochem. 2018 Jun;56:165-174. doi: 10.1016/j.jnutbio.2018.01.002. Epub 2018 Mar 20. PMID: 29571010
Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, Mullany EC, Biryukov S, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2014. Lancet, 384(9945):766-81. https://doi.org/10.1016/S0140-6736(14)60460-8
Kobyliak N, Conte C, Cammarota G, Haley AP, Styriak I, Gaspar L, Kruzliak P. Probiotics in prevention and treatment of obesity : a critical view. Nutrition & Metabolism. 2016; 13, 14. http://doi.org/10.1186/s12986-016-0067-0
Murugesan S, Ulloa-Martínez M, Martínez-Rojano H, Galván-Rodríguez FM, Miranda Brito C, Romano MC et al. Study of the diversity and short-chain fatty acids production by the bacterial community in overweight and obese Mexican children. Eur J ClinMicrobiol Infect Dis. 2015; 34:1337–1346. http://doi.org/10.1007/s10096-015-2355-4
Schwiertz A, Taras D, Schäfer K, Beijer S, Bos NA, Donus C, Hardt PD. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring). 2010 Jan;18(1):190-5. https://doi.org/10.1038/oby.2009.167
Nagata S, Chiba Y, Wang C & Yamashiro Y. The effects of the Lactobacillus casei strain on obesity in children: A pilot study. Beneficial Microbes, 2017; 8(4), 535–543. https://doi.org/10.3920/BM2016.0170
Rahat-Rozenbloom S, Fernandes J, Gloor GB, Wolever TM. Evidence for greater production of colonic short-chain fatty acids in overweight than lean humans. Int J Obes (Lond). 2014 Dec;38(12):1525-31. https://doi.org/10.1038/ijo.2014.46
Arora T, Singh S, Sharma RK. Probiotics: Interaction with gut microbiome and antiobesity potential. Nutrition. 2013;29(4):591-596. https://doi.org/10.1016/j.nut.2012.07.017
Payne AN, Chassard C, Zimmermann M, Müller P, Stinca S, & Lacroix C. The metabolic activity of gut microbiota in obese children is increased compared with normal-weight children and exhibits more exhaustive substrate utilization. Nutrition & Diabetes, 1, 2011; e12. https://doi.org/10.1038/nutd.2011.8
Teixeira TF, Grześkowiak Ł, Franceschini SC, Bressan J, Ferreira CL, Peluzio MC. Higher level of faecal SCFA in women correlates with metabolic syndrome risk factors. Br J Nutr. 2013;109(5):914-919. https://doi.org/10.1017/S0007114512002723
Wang C, Nagata S, Asahara T, et al. Intestinal Microbiota Profiles of Healthy Pre-School and School-Age Children and Effects of Probiotic Supplementation. Ann Nutr Metab. 2015;67(4):257-266. https://doi.org/10.1159/000441066
Khan MJ, Gerasimidis K, Edwards CA, Shaikh MG. Role of Gut Microbiota in the Aetiology of Obesity: Proposed Mechanisms and Review of the Literature. J Obes. 2016;2016:7353642. https://doi.org/10.1155/2016/7353642
Matsumoto K, Takada T, Shimizu K, et al. Effects of a probiotic fermented milk beverage containing Lactobacillus casei strain Shirota on defecation frequency, intestinal microbiota, and the intestinal environment of healthy individuals with soft stools. J Biosci Bioeng. 2010;110(5):547-552. https://doi.org/10.1016/j.jbiosc.2010.05.016
Spanhaak S, Havenaar R, Schaafsma G. The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans. Eur J Clin Nutr. 1998;52(12):899-907. https://doi.org/10.1038/sj.ejcn.1600663
Joseph N, Vasodavan K, Saipudin NA, Yusof BNM, Kumar S, Nordin SA. Gut microbiota and short-chain fatty acids (SCFAs) profiles of normal and overweight school children in Selangor after probiotics administration. Journal of Functional Foods. 2019 Jun 1;57:103–11. https://doi.org/10.1016/j.jff.2019.03.042
Julious SA. Sample sizes for clinical trials with normal data. Stat Med. 2004 Jun 30;23(12):1921-86. doi: 10.1002/sim.1783. PMID: 15195324.
Saipudin, N. A., Suhairom, N., & Abd Wahid, N. H. (2022). A Comparative Study on Faecal Short-Chain Fatty Acids Concentration in Lean, Overweight and Obese School Children. Asian Journal of Medicine and Biomedicine, 6(1), 77-83. https://doi.org/10.37231/ajmb.2022.6.1.465
World Health Organization 2007 Growth Chart for Children 5–19 years. Geneva: WHO. http://www.who.int/growthref/en/ (accessed July 2020).
Huda-Faujan N, Abdulamir AS, Fatimah AB, et al. The impact of the level of the intestinal short chain Fatty acids in inflammatory bowel disease patients versus healthy subjects. Open Biochem J. 2010;4:53-58. Published 2010 May 13. https://doi.org/10.2174/1874091X01004010053
Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997;32(9):920-924. https://doi.org/10.3109/00365529709011203
Wong JM, de Souza R, Kendall CW, Emam A, Jenkins DJ. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol. 2006;40(3):235-243. https://doi.org/10.1097/00004836-200603000-00015
Macfarlane GT, Macfarlane S. Models for intestinal fermentation: association between food components, delivery systems, bioavailability and functional interactions in the gut. Curr Opin Biotechnol. 2007;18(2):156-162 https://doi.org/10.1016/j.copbio.2007.01.011
Everard A, Belzer C, Geurts L, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A. 2013;110(22):9066-9071. https://doi.org/10.1073/pnas.1219451110
Huazano-García A, & López M. Metabolism of short chain fatty acids in the colon and faeces of mice after a supplementation of diets with agave fructans. Intech 2013; pp. 163–182. https://doi.org/10.5772/51248
Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444(7122):1027-1031. https://doi.org/10.1038/nature05414
Matsumoto K, Takada T, Shimizu K, et al. Effects of a probiotic fermented milk beverage containing Lactobacillus casei strain Shirota on defecation frequency, intestinal microbiota, and the intestinal environment of healthy individuals with soft stools. J Biosci Bioeng. 2010;110(5):547-552. https://doi.org/10.1016/j.jbiosc.2010.05.016
Spanhaak S, Havenaar R, Schaafsma G. The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans. Eur J Clin Nutr. 1998;52(12):899-907. https://doi.org/10.1038/sj.ejcn.1600663
Bridgman SL, Azad MB, Field CJ, Haqq AM, Becker AB, Mandhane PJ, et al. Fecal Short-Chain Fatty Acid Variations by Breastfeeding Status in Infants at 4 Months: Differences in Relative versus Absolute Concentrations. Frontiers in Nutrition [Internet]. 2017 [cited 2022 Sep 26];4. Available from: https://www.frontiersin.org/articles/10.3389/fnut.2017.00011
den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud D-J, & Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. Journal of Lipid Research, 2013; 54, 2325–2340. https://doi.org/10.1194/jlr.R036012
Koebnick C, Wagner I, Leitzmann P, Stern U, Zunft HJ. Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. Can J Gastroenterol. 2003;17(11):655-659. https://doi.org/10.1155/2003/654907
Stenman LK, Waget A, Garret C, Klopp P, Burcelin R, Lahtinen S. Potential probiotic Bifidobacterium animalis ssp. lactis 420 prevents weight gain and glucose intolerance in diet-induced obese mice. Benef Microbes. 2014;5(4):437-445. https://doi.org/10.3920/BM2014.0014
Omar JM, Chan YM, Jones ML, Prakash S, Jones PJH. Lactobacillus fermentum and Lactobacillus amylovorus as probiotics alter body adiposity and gut microflora in healthy persons. Journal of Functional Foods. 2013;5(1):116-123. https://doi.org/10.1016/j.jff.2012.09.001
Karimi G, Sabran MR, Jamaluddin R, et al. The anti-obesity effects of Lactobacillus casei strain Shirota versus Orlistat on high fat diet-induced obese rats. Food Nutr Res. 2015;59:29273. Published 2015 Dec 22. https://doi.org/10.3402/fnr.v59.29273
